Funding
Funding not disclosed
Founders
Product
Problem
Current Natural Killer (NK) cell therapies for cancers like leukemia, multiple myeloma, lymphoma, and solid tumors often come with high costs and significant side effects, limiting accessibility and tolerability for many patients. This creates a need for more affordable and less toxic NK cell-based treatment options.
Solution
NKure is developing a novel approach to NK-cell based therapies, focusing on affordability and reduced side effects. Their platform aims to provide cancer patients with accessible therapeutic options, potentially enhancing treatment efficacy while minimizing costs and improving tolerability across diverse patient profiles. This approach seeks to broaden the availability of NK cell therapies and improve patient outcomes.
Target Audience
The primary target audience includes cancer patients with leukemia, multiple myeloma, lymphoma, and solid tumors, as well as healthcare providers seeking more affordable and less toxic NK cell therapy options.
Features
- Development of NK-cell based therapies
- Focus on affordability to increase patient access
- Aim to reduce side effects associated with current NK cell therapies
- Targeting a range of cancers including leukemia, multiple myeloma, lymphoma, and solid tumors